Searched for
V.K. PAUL
Ashok Lahiri takes charge as Niti VCEconomist Ashok Kumar Lahiri has assumed the role of vice chairman at Niti Aayog, succeeding Suman Bery. A former chief economic adviser an...- NITI Aayog gets two new full-time membersThis takes the total number of members in the Aayog to seven, after Prime Minister Narendra Modi last month restructured the institution wi...
- Dr Nikhil Tandon appointed as officiating Director of AIIMS DelhiDr Nikhil Tandon is now the officiating Director of AIIMS Delhi. He will hold this role for six months or until a permanent Director is cho...
- Govt reconstitutes NITI Aayog, appoints new vice chairman; membersThe government has reconstituted NITI Aayog with five new members and Ashok Lahiri as Vice Chairman. Rajiv Gauba, Prof. K. V. Raju, Prof. G...
- India needs an action plan to create a stimulating environment for children aged 0-3 years: VK PaulSpeaking at the Early Childhood Care and Education (ECCE) seminar organised by Rocket Learning, Dr Paul said, “With 85% of brain developmen...
- Arvind Virmani appointed full-time member of NITI Aayog. Here's all you need to know about the noted economistFormer Chief Economic Advisor Arvind Virmani has been appointed as a full-time member of NITI Aayog, according to an official notification....
- Task force on Monkeypox set up as India sees 1st deathThe National Institute of Virology (NIV) in Pune on Monday confirmed the death of a 22-year-old man from Thrissur in Kerala as the first ca...
- India resumes vaccine exports as domestic stocks build up - officialsOne million shots of Covaxin produced by Indian company Bharat Biotech were shipped to Iran last week, the Indian embassy in Tehran said.
- No talk of Covid booster shots yet, plan to jab adult population first: Niti Aayog member VK PaulIn response to the chairman of the Serum Institute of India, Cyrus Poonawalla, emphasising the necessity for a third or booster dosage of C...
- Next 100-125 days critical to prevent third wave, says top govt official"Leaving the North and South American regions, all other WHO regions are moving from bad to worse. The world is moving towards a third wave...
- Both doses of vaccine provide around 98 per cent protection from death due to Covid: Govt citing studySharing the data of the study, NITI Aayog member (Health) Dr V K Paul said 4,868 police personnel were not vaccinated and out of them, 15 d...
- Delta+ variant not yet classified as 'Variant of Concern': Niti Aayog's V.K. PaulAs 'Delta Plus' is not yet classified as a VOC, Paul said, the way forward is to watch the potential presence of 'Delta Plus' in the countr...
- No need to panic on need for immediate change in dosage interval of Covishield: GovtPaul said in the National Technical Advisory Group on Immunisation (NTAGI), there are quite a few people who have been a part of WHO panels...
- Centre enforces price cap on vaccines for private sector: Most you'll spend on a jab is Rs 1,410With Prime Minister Modi announcing a price cap on service charges for Covid-19 vaccines at private hospitals on Monday, vaccines prices ac...
- Covaxin trials begin for children at AIIMS PatnaEarlier in the week, NITI Aayog's Member Health, Dr V.K. Paul said: "Covaxin has been approved by the Drugs Controller General of India (DC...
- No change to India's two-dose schedule for Covishield vaccine: Govt adviser V K Paul"India's Covishield schedule is of two doses... there is no change and Covaxin is also for two doses," government advisor V K Paul told rep...
- Pandemic now in Tier II, III cities: V K PaulEarlier on Wednesday, Prime Minister Narendra Modi said that India needs to take quick and decisive steps to stop the emerging second peak ...
- New coronavirus strain still not found in India: OfficialsV.K. Paul, a top COVID-19 adviser to Prime Minister Narendra Modi, said the new virus strain would have no impact on vaccines being develop...
- Expert committee on COVID-19 vaccine administration to meet on WednesdayThe phase-1 human clinical trials of the two COVID-19 vaccine candidates, developed indigenously by Bharat Biotech in collaboration with th...
- Niti Aayog, stakeholders discuss R&D requirement for coronavirus vaccineThe deadly virus, which originated in China in December last year, has spread to 155 countries, infected more than 180,000 people and claim...
Load More
